Effect of low fluence diode laser irradiation on the hydraulic conductivity of perfused trabecular meshwork endothelial cell monolayers

Current Eye Research

Volumn 32, Issue 7-8, 2007, Pages 625-638

  Roberts, Cynthia J ^a,b   Rivera, Brian K ^a   Grzybowski, Deborah M ^b   Mahmoud, Ashraf M ^a   Weber, Paul A ^b  

^a The Ohio State University

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Glaucoma; Hydraulic conductivity; Laser trabeculoplasty; Perfusion; Trabecular meshwork

Indexed keywords

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DIODE LASER; ENDOTHELIUM CELL; FLUID FLOW; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDRAULIC CONDUCTIVITY; HYDROSTATIC PRESSURE; INFORMATION PROCESSING; MONOLAYER CULTURE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; TRABECULAR MESHWORK; TREATMENT RESPONSE;

AQUEOUS HUMOR; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DEXAMETHASONE; ENDOTHELIAL CELLS; EYE PROTEINS; GLUCOCORTICOIDS; GLYCOPROTEINS; HUMANS; HYDROSTATIC PRESSURE; LASER THERAPY, LOW-LEVEL; MEMBRANE PROTEINS; PHOSPHOPROTEINS; TRABECULAR MESHWORK;

EID: 34548607037     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680701486394     Document Type: Article

References (95)

1. Goldberg I. Argon laser trabeculoplasty and the open-angle glaucomas. Aust NZ J Ophthalmol. 1985;13:243:248.
2. Shirato S, et al. Argon laser trabeculoplasty in open-angle glaucoma. Jpn J Ophthalmol. 1982;26: 374-386.
3. Schwartz AL, et al. Argon laser trabecular surgery in uncontrolled phakic open-angle glaucoma. Ophthalmol. 1981;88:203-212.
4. Thomas JV, et al. Argon laser trabeculoplasty in the presurgical glaucoma patient. Ophthalmol. 1982;89:187-197.
5. Welch RT, Hadden OB. Argon laser trabeculoplasty. Trans Ophthalmol Soc NZ. 1984;36:61-63.
6. Wilensky JT, Jampol LM. Laser therapy for open-angle glaucoma. Ophthalmol. 1981;88:213-217.
7. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma. Arch Ophthalmol. 1979;97:319-322.
8. Wise, J.B., 1981 Glaucoma treatment by trabecular tightening with the argon laser. Int Ophthalmol Clin. 21:69-78.
9. Spurny RC, Lederer CM. Krypton laser trabeculoplasty: A clinical report. Arch Ophthalmol. 1984;102:1626-1628.
10. Belgrado G, et al. Comparison of argon and CW Nd:YAG laser trabeculoplasty. In: Marshall J (ed.) Laser technology in ophthalmology. Berkeley, CA: Kugler Publications, 1988;45-52.
11. Del Priore LV, et al. Long-term follow-up of neodymium:YAG laser angle surgery for open-angle glaucoma. Ophthalmol. 1988;95:277-281.
12. Hollo G. Argon and low energy, pulsed Nd:YAG laser trabeculoplasty: A prospective, comparative clinical and morphological study. Acta Ophthalmol Scand. 1996;74:126-131.
13. Robin AL, Pollack IP. Q-switched Neodynium-YAG laser angle aurgery in open-angle glaucoma. Arch Ophthalmol. 1985;103:793-795.
14. Brancato R, Carassaet R, Trabucchi G. Diode laser compared with Argon laser for trabeculoplasty. Am J Ophthalmol. 1991;112:50-55.
15. McHugh D, et al. Diode laser trabeculoplasty (DLT) for primary open-angle glaucoma and ocular hypertension. Br J Ophthalmol. 1990;74:743-747.
16. Vicary DL. Diode laser trabeculoplasty. Aust NZ J Ophthalmol. 1991;19:305-307.
17. Eguchi S, et al. Methods of Argon laser trabeculoplasty, complications, and long-term follow-up of the results. Jpn J Ophthalmol. 1985;29:198-211.
18. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT). 2. Results of Argon laser trabeculoplasty versus topical medicines. Ophthalmol. 1990;97:1403-1413.
19. Grinich NP, et al. Three-year efficacy of Argon laser trabeculoplasty. Ophthalmol. 1987;94:858-861.
20. Schwartz AL, Kopelman J. Four-year experience with Argon laser trabecular surgery in uncontrolled open-angle glaucoma. Ophthalmol. 1983;90:771-780.
21. Wise JB, Long-term control of adult open angle glaucoma by Argon laser treatment. Ophthalmol. 1981;88:197-202.
22. Brooks AM, et al. Argon laser trabeculoplasty five years on. Aust NZ J Ophthalmol. 1988;16:343-351.
23. Gillies WE, et al. Long-term results with Argon laser trabeculoplasty. Aust N Z J Ophthalmol. 1994;22:39-43.
24. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow-Up Study: 7. Results. Am J Ophthalmol. 1995;120:718-731.
25. Schwartz AL, et al. Long-term follow-up of Aargon laser trabeculoplasty for uncontrolled open-angle glaucoma. Arch Ophthalmol. 1985;103:1482-1484.
26. Shingleton BJ, et al. Long-term efficacy of Argon laser trabeculoplasty: a 10-year follow-up study. Ophthalmol. 1993;100:1324-1329.
27. Spaeth GL, Baez KA. Argon laser trabeculoplasty controls one third of cases of progressive, uncontrolled, open angle glaucoma for 5 years. Arch Ophthalmol. 1992;110:491-494.
28. Alexander RA, et al. The effect of Argon laser trabeculoplasty upon the normal human trabecular meshwork. Graefes Arch Clin Exp Ophthalmol. 1989;227:72-77.
29. Alexander RA, Grierson I. Morphological effects of Argon laser trabeculoplasty upon the glaucomatous human meshwork. Eye. 1989;3:719-726.
30. Babizhayev MA, et al. Clinical, structural, and molecular phototherapy effects of laser irradiation on the trabecular meshwork of human glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol. 1990;228:90-100.
31. Fankhauser F, et al. Thermal effects on the trabecular meshwork induced by laser irradiation: clinical implications deduced from ultrastructural studies on the Macaca speciosa monkey. Trans Ophthalmol Soc UK. 1986;105:555-561.
32. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and Argon laser trabeculoplasty in human eye bank eyes. Ophthalmol. 2001;108:773-779.
33. McHugh D, et al. Ultrastructural changes of human trabecular meshwork after photocoagulation with a diode laser. Invest Ophthalmol Vis Sci. 1992;33:2664-2671.
34. McMillan TA, et al. Comparison of diode and Argon laser trabeculoplasty in cadaver eyes. Invest Ophthalmol Vis Sci. 1994;35:706-710.
35. Rodrigues MM, et al. Electron microscopy of Argon laser therapy in phakic open-angle glaucoma. Ophthalmol. 1982;89:198-210.
36. Van der Zypen E, Fankhouser F. Ultrastructural changes of the trabecular meshwork of the monkey (Macaca speciosa) following irradiation with Argon laser light. Graefes Arch Clin Exp Ophthalmol. 1984;221:249-261.
37. Van der Zypen E, et al. Morphology of the trabecular meshwork within monkey (Macaca speciosa) eyes after irradiation with the free-running Nd:YAG laser. Ophthalmol. 1987;94:171-179.
38. Weber PA, et al. Scanning electron microscopy of Argon laser trabeculoplasty. Ophthalmic Forum. 1983;1:26-29.
39. Melamed S, Epstein DL. Alterations of aqueous humor outflow following argon laser trabeculoplasty in monkeys. Br J Ophthalmol. 1987;71:776-781.
40. Brubaker RF, Liesegang TJ. Effect of trabecular photocoagulation on the aqueous humor dynamics of the human eye. Am J Ophthalmol. 1983;96:139-147.
41. Yablonski ME, et al. A fluorophotometric study of the effect of argon laser trabeculoplasty on aqueous humor dynamics. Am J Ophthalmol. 1985;99:579-582.
42. Brown SV, et al. Laser trabeculoplasty re-treatment. Am J Ophthalmol. 1985;99:8-10.
43. Feldman RM, et al. Long-term efficacy of repeat Argon laser trabeculoplasty. Ophthalmol. 1991;98:1061-1065.
44. Messner D, et al. Repeat Argon laser trabeculoplasty. Am J Ophthalmol. 1987;103:113-115.
45. Richter CU, et al. Retreatment with Argon laser trabeculoplasty. Ophthalmol. 1987;94:1085-1089.
46. Starita RJ, et al. The effect of repeating full-circumference Argon laser trabeculoplasty. Ophthalmic Surg. 1984.15:41-43
47. Weber PA, et al. Laser trabeculoplasty retreatment. Ophthalmic Surg. 1989;20:702-706.
48. Latina MA, et al. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty). A multicenter, pilot, clinical study. Ophthalmol. 1998;105:2082-2090.
49. Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res. 1995;60:359-371.
50. Damji KF, et al. Selective laser trabeculoplasty v Argon laser trabeculoplasty: a prospective randomised clinical trial. Br J Ophthalmol. 1999;83:718-722.
51. Reno JB, et al. A retrospective comparison of selective laser trabeculoplasty versus Argon laser trabeculoplasty in chronic open angle glaucoma patients. Invest Ophthalmol Vis Sci. ARVO Abstracts. 1999;40:1428.
52. Ethier CR, et al. Calculations of flow resistance in the juxtacanalicular meshwork. Invest Ophthalmol Vis Sci. 1986;27:1741-1750.
53. Ethier CR, et al. Retroperfusion studies of the aqueous outflow system. Part 2: Studies in human eyes. Invest Ophthalmol Vis Sci. 1995;36:2466-2475.
54. Ethier CR, et al. Two pore types in the inner-wall endothelium of Schlemm's canal. Invest Ophthalmol Vis Sci. 1998;39:2041-2048.
55. Ethier CR. The inner wall of Schlemm's canal. Exp Eye Res. 2002;74:161-172.
56. Johnson M, et al. Modulation of outflow resistance by the pores of the inner wall endothelium. Invest Ophthalmol Vis Sci. 1992 ;33:1670-1675.
57. Johnson M, et al. The pore density in the inner wall endothelium of Schlemm's canal of glaucomatous eyes. Invest Ophthalmol Vis Sci. 2002;43:2950-2955.
58. Maepea O, Bill A. The pressures in the episcleral veins, Schlemm's canal, and the trabecular meshwork in monkeys: effects of changes in intraocular pressure. Exp Eye Res. 1989;49:645-663.
59. Maepea O, Bill A. Pressures in the juxtacanalicular tissue and Schlemm's canal in monkeys. Exp Eye Res. 1992;54:879-883.
60. Seiler T, Wollensak J. The resistance of the trabecular meshwork to aqueous humor outflow. Graefes Arch Clin Exp Ophthalmol. 1985;223:88-91.
61. Sit AJ, et al. Factors affecting the pores of the inner wall endothelium of Schlemm's canal. Invest Ophthalmol Vis Sci. 1997;38:1517-1525.
62. Johnson M. What controls aqueous humor outflow resistance? Exp Eye Res. 2005;82:545-557.
63. Farrar SK, et al. Optical properties of human trabecular meshwork in the visible and near-infrared region. Lasers Surg Med. 1999;25:348-362.
64. Rivera BK, et al. Preliminary experiments using a new in vitro cellular perfusion system. Invest Ophthalmol Vis Sci. ARVO Abstracts. 1998;39:S483.
65. Rivera BK, et al. Characterization of a low energy laser irradiation and cellular perfusion system for trabecular meshwork cell monolayers. Invest Ophthalmol Vis Sci. ARVO Abstracts. 1999;40:S669.
66. Rivera BK, et al. Low energy laser irradiation of perfused trabecular meshwork cell monolayers: results of a pilot experimental series using a diode laser. Invest Ophthalmol Vis Sci. ARVO Abstracts. 2001;42:S138.
67. Alvarado JA, et al. Human trabecular cells II. Growth pattern and ultrastructural characteristics. Invest Ophthalmol Vis Sci. 1982;23:464-478.
68. Chang IL, et al. Expression of modified low-density lipoprotein receptors by trabecular meshwork cells. Curr Eye Res. 1991;10:1101-1112.
69. Erickson-Lamy K, et al. Ethacrynic acid induces reversible shape and cytoskeletal changes in cultured cells. Invest Ophthalmol Vis Sci. 1992;33:2631-2640.
70. Hernandez MR, et al. Human trabecular meshwork cells in culture: morphology and extracellular matrix components. Invest Ophthalmol Vis Sci. 1987;28:1655-1660.
71. Iwamoto Y, Tamura M. Immunocytochemical study of intermediate filaments in cultured human trabecular cells. Invest Ophthalmol Vis Sci. 1988;29:244-250.
72. Pang IH, et al. 1994. Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr Eye Res. 1994;13:51-63.
73. Polansky JR, et al. Trabecular meshwork cell culture in glaucoma research: evaluation of biological activity and structural properties of human trabecular meshwork cells in vitro. Ophthalmol. 1984;91:580-595.
74. Ryder MI, et al. The cytoskeleton of the cultured human trabecular cell. Characterization and drug responses. Invest Ophthalmol Vis Sci. 1988;29:251-260.
75. Tamura M, et al. Immunofluorescence studies of the cytoskeletal and contractile elements in cultured trabecular meshwork cells. Jpn J Ophthalmol. 33:95-102.
76. Yun AJ, et al. Proteins secreted by human trabecular cells. Glucocorticoid and other effects. Invest Ophthalmol Vis Sci. 1989;30:2012-2022.
77. Zhou L, et al. Adhesion of human trabecular meshwork cells to extracellular matrix proteins. Roles and distribution of integrin receptors. Invest Ophthalmol Vis Sci. 1996;37:104-113.
78. Stamer WD, et al. Isolation, culture, and characterization of endothelial cells from Schlemm's canal. Invest Ophthalmol Vis Sci. 1998;39:1804-1812.
79. O'Brien ET, et al. Immunofluorescence method for quantifying the trabecular meshwork glucocorticoid (TIGR) protein in trabecular meshwork and Schlemm's canal cells. Curr Eye Res. 1999;19:517-524.
80. Rivera BK, et al. Dual-purpose laser irradiation and perfusion testing system for in vitro experiments using cultured trabecular meshwork endothelial cells. SPIE Proceedings. 1998;3246:2-13.
81. Perkins TW, et al. Flow resistance measurements in cultured cells using a filter supported system. Invest Ophthalmol Vis Sci. 1987;28(Supp):132.
82. Perkins TW, et al. 1988. Trabecular meshwork cells grown on filters: conductivity and cytochalasin effects. Invest Ophthalmol Vis Sci. 1988;29:1836-1846.
83. Alvarado JA, et al. Epinephrine effects on major cell types of the aqueous outflow pathway: in vitro studies/clinical implications. Trans Am Ophthalmol Soc. 1990;88:267-282.
84. Alvarado JA, et al. Effect of β-adrenergic agonists on paracellular width and fluid flow across outflow pathway cells. Invest Ophthalmol Vis Sci. 1998;39:1813-1822.
85. Alvarado JA, et al. Endothelia of Schlemm's canal and trabecular meshwork: distinct molecular, functional, and anatomic features. Am J Physiol Cell Physiol. 2004;286:C621-C634.
86. Alvarado JA, Yeh RF, Franse-Carman L, Marcellino G, Brownstein MJ. Interactions between endothelia of the trabecular meshwork and of Schlemm's canal: a new insight into the regulation of aqueous outflow in the eye. Trans Am Ophthalmol Soc. 2005;103:148-162.
87. Alvarado JA, Alvarado RG, Yeh RF, Franse-Carman L, Marcellino GR, Brownstein MJ. A new insight into the cellular regulation of aqueous outflow: how trabecular meshwork endothelial cells drive a mechanism that regulates the permeability of Schlemm's canal endothelial cells. Br J Ophthalmol. 2005;89(11):1500-1505.
88. Chang YS, et al. Shear-induced increase in hydraulic conductivity in endothelial cells is mediated by a nitric oxidedependent mechanism. Arterioscler Thromb Vasc Biol. 2000;20:35-42.
89. Bao X, et al. Mechanism of temporal gradients in shear-induced ERK1/2 activation and proliferation in endothelial cells. Am J Physiol Heart Circ Physiol. 2001;281:H22-H29.
90. Bao X, et al. Temporal gradient in shear-induced signaling pathway: involvement of MAP kinase, c-fos, and connexin43. Am J Physiol Heart Circ Physiol. 2000;278:H1598-H1605.
91. Clark CB, et al. Strain and strain rate activation of G proteins in human endothelial cells. Biochem Biophys Res Comm. 2002;299:258-262.
92. Bill A, Svedberg B. Scanning electron microscopic studies of the trabecular meshwork and the canal of Schlemm - an attempt to localize the main resistance to outflow of aqueous humor in man. Acta Ophthalmol. 1972;50:295-320.
93. Johnson MC, Kamm RD. The role of Schlemm's canal in aqueous out-flow from the human eye. Invest Ophthalmol Vis Sci. 1983;24:320-325.
94. McEwen WK. Application of Poiseuille's law to aqueous outflow. Arch Ophthalmol. 1958;60:290-294.
95. Moseley H, et al. Mathematical modeling of aqueous humor outflow from the eye through the pores in the lining endothelium of Schlemm's canal. Clin Phys Physiol Meas. 1983;4:47-63.